Sleep & RecoveryResearch PaperPaywall

Nearly Half of Men Have Sleep Apnea in Major Brazilian Study of 769 Adults

New research reveals 37% of adults have obstructive sleep apnea, with men nearly twice as likely to be affected as women.

Sunday, March 29, 2026 0 views
Published in Journal of sleep research
Scientific visualization: Nearly Half of Men Have Sleep Apnea in Major Brazilian Study of 769 Adults

Summary

A major Brazilian study of 769 adults found that 37% have obstructive sleep apnea (OSA), with men significantly more affected than women (45% vs 31%). Using gold-standard sleep lab testing, researchers discovered that age, higher body weight, and male gender were the strongest risk factors. Moderate to severe cases affected nearly 20% of participants. This suggests OSA is far more common than previously recognized, potentially impacting millions who remain undiagnosed. Since untreated sleep apnea increases risks of cardiovascular disease, diabetes, and cognitive decline, these findings highlight an urgent need for better screening and treatment access to protect long-term health.

Detailed Summary

Obstructive sleep apnea may be dramatically underdiagnosed, with new research revealing that more than one-third of adults suffer from this serious sleep disorder that threatens cardiovascular health and longevity. The condition, which causes repeated breathing interruptions during sleep, affects nearly 1 billion people worldwide and significantly increases risks of heart disease, stroke, diabetes, and cognitive decline.

Brazilian researchers conducted the fourth edition of the EPISONO study, examining 769 adults aged 20-80 in São Paulo through comprehensive overnight sleep laboratory testing. This rigorous approach used polysomnography, the gold standard for sleep apnea diagnosis, rather than relying on questionnaires or home testing that can miss cases.

The results were striking: 37% of participants had obstructive sleep apnea, with men disproportionately affected at 45% compared to 31% of women. Nearly 20% had moderate to severe cases requiring immediate treatment. Age, higher body mass index, and male gender emerged as the strongest risk factors, with prevalence increasing significantly in older age groups.

These findings have profound implications for healthy aging and longevity. Untreated sleep apnea fragments sleep architecture, elevates inflammation, and stresses the cardiovascular system nightly. The high prevalence suggests millions remain undiagnosed, missing opportunities for interventions like CPAP therapy, weight management, or positional therapy that can restore healthy sleep patterns.

The study's limitations include its focus on one Brazilian city, though the rigorous sampling methodology strengthens generalizability. The researchers emphasize urgent needs for scalable screening programs and equitable treatment access, as addressing this widespread but treatable condition could significantly impact population health and longevity outcomes.

Key Findings

  • 37% of adults have obstructive sleep apnea, with men affected at nearly twice the rate of women
  • Nearly 20% of participants had moderate to severe sleep apnea requiring immediate treatment
  • Age, higher BMI, and male gender are the strongest risk factors for developing sleep apnea
  • Gold-standard sleep lab testing reveals much higher prevalence than previous estimates

Methodology

Cross-sectional study using 4-stage cluster sampling of 769 adults aged 20-80 in São Paulo, Brazil. All participants underwent full-night polysomnography in sleep laboratories and completed validated sleep questionnaires. OSA diagnosis followed current American Academy of Sleep Medicine guidelines.

Study Limitations

Study limited to São Paulo population, potentially limiting generalizability to other regions or ethnicities. Cross-sectional design prevents assessment of causality or long-term health outcomes. Single-night polysomnography may not capture night-to-night variability in sleep apnea severity.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.